GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TherapeuticsMD Inc (STU:29TA) » Definitions » Cyclically Adjusted Book per Share

TherapeuticsMD (STU:29TA) Cyclically Adjusted Book per Share : €12.07 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is TherapeuticsMD Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

TherapeuticsMD's adjusted book value per share for the three months ended in Mar. 2024 was €2.287. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €12.07 for the trailing ten years ended in Mar. 2024.

During the past 12 months, TherapeuticsMD's average Cyclically Adjusted Book Growth Rate was -10.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 41.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of TherapeuticsMD was 41.30% per year. The lowest was -56.70% per year. And the median was -17.30% per year.

As of today (2024-06-07), TherapeuticsMD's current stock price is €1.86. TherapeuticsMD's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €12.07. TherapeuticsMD's Cyclically Adjusted PB Ratio of today is 0.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of TherapeuticsMD was 19.77. The lowest was 0.14. And the median was 1.15.


TherapeuticsMD Cyclically Adjusted Book per Share Historical Data

The historical data trend for TherapeuticsMD's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TherapeuticsMD Cyclically Adjusted Book per Share Chart

TherapeuticsMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.95 3.79 11.39 13.97 12.73

TherapeuticsMD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.52 13.60 12.83 12.73 12.07

Competitive Comparison of TherapeuticsMD's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, TherapeuticsMD's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TherapeuticsMD's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TherapeuticsMD's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where TherapeuticsMD's Cyclically Adjusted PB Ratio falls into.



TherapeuticsMD Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TherapeuticsMD's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.287/131.7762*131.7762
=2.287

Current CPI (Mar. 2024) = 131.7762.

TherapeuticsMD Quarterly Data

Book Value per Share CPI Adj_Book
201406 9.452 100.560 12.386
201409 15.815 100.428 20.752
201412 12.570 99.070 16.720
201503 23.472 99.621 31.048
201506 16.221 100.684 21.230
201509 19.434 100.392 25.510
201512 16.268 99.792 21.482
201603 41.953 100.470 55.025
201606 37.877 101.688 49.084
201609 33.167 101.861 42.908
201612 30.724 101.863 39.747
201703 25.973 102.862 33.274
201706 20.413 103.349 26.028
201709 28.974 104.136 36.665
201712 25.360 104.011 32.130
201803 20.090 105.290 25.144
201806 15.306 106.317 18.971
201809 24.321 106.507 30.091
201812 17.825 105.998 22.160
201903 11.134 107.251 13.680
201906 1.485 108.070 1.811
201909 -3.995 108.329 -4.860
201912 1.527 108.420 1.856
202003 -7.530 108.902 -9.112
202006 -15.342 108.767 -18.587
202009 -18.055 109.815 -21.666
202012 -17.001 109.897 -20.386
202103 -1.012 111.754 -1.193
202106 -5.155 114.631 -5.926
202109 -5.738 115.734 -6.533
202112 -9.637 117.630 -10.796
202203 -14.725 121.301 -15.997
202206 -2.783 125.017 -2.933
202209 -5.150 125.227 -5.419
202212 3.493 125.222 3.676
202303 3.133 127.348 3.242
202306 2.723 128.729 2.787
202309 2.486 129.860 2.523
202312 2.329 129.419 2.371
202403 2.287 131.776 2.287

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


TherapeuticsMD  (STU:29TA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

TherapeuticsMD's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.86/12.07
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of TherapeuticsMD was 19.77. The lowest was 0.14. And the median was 1.15.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


TherapeuticsMD Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of TherapeuticsMD's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


TherapeuticsMD (STU:29TA) Business Description

Industry
Traded in Other Exchanges
Address
951 Yamato Road, Suite 220, Boca Raton, FL, USA, 33431
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

TherapeuticsMD (STU:29TA) Headlines

No Headlines